Catalyst
Slingshot members are tracking this event:
Acadia Pharmaceuticals (ACAD) Announces Top-line Results from the Pivotal Phase 3 Lavender Trial of Trofinetide in Rett Syndrome
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
ACAD |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 06, 2021
Related Projects
Related Keywords
Trofinetide, Rett Syndrome, Lavender Trial